126 related articles for article (PubMed ID: 32012325)
1. Characterizing Hepatitis C Virus-Specific CD4
Hartnell F; Esposito I; Swadling L; Brown A; Phetsouphanh C; de Lara C; Gentile C; Turner B; Dorrell L; Capone S; Folgori A; Barnes E; Klenerman P
Hepatology; 2020 Nov; 72(5):1541-1555. PubMed ID: 32012325
[TBL] [Abstract][Full Text] [Related]
2. Functional restoration of HCV-specific CD8 T cells by PD-1 blockade is defined by PD-1 expression and compartmentalization.
Nakamoto N; Kaplan DE; Coleclough J; Li Y; Valiga ME; Kaminski M; Shaked A; Olthoff K; Gostick E; Price DA; Freeman GJ; Wherry EJ; Chang KM
Gastroenterology; 2008 Jun; 134(7):1927-37, 1937.e1-2. PubMed ID: 18549878
[TBL] [Abstract][Full Text] [Related]
3. Will there be a vaccine to prevent HCV infection?
Honegger JR; Zhou Y; Walker CM
Semin Liver Dis; 2014 Feb; 34(1):79-88. PubMed ID: 24782261
[TBL] [Abstract][Full Text] [Related]
4. A novel adenovirus type 6 (Ad6)-based hepatitis C virus vector that overcomes preexisting anti-ad5 immunity and induces potent and broad cellular immune responses in rhesus macaques.
Capone S; Meola A; Ercole BB; Vitelli A; Pezzanera M; Ruggeri L; Davies ME; Tafi R; Santini C; Luzzago A; Fu TM; Bett A; Colloca S; Cortese R; Nicosia A; Folgori A
J Virol; 2006 Feb; 80(4):1688-99. PubMed ID: 16439526
[TBL] [Abstract][Full Text] [Related]
5. Successful vaccination induces multifunctional memory T-cell precursors associated with early control of hepatitis C virus.
Park SH; Shin EC; Capone S; Caggiari L; De Re V; Nicosia A; Folgori A; Rehermann B
Gastroenterology; 2012 Oct; 143(4):1048-60.e4. PubMed ID: 22705008
[TBL] [Abstract][Full Text] [Related]
6. Use of an Outbred Rat Hepacivirus Challenge Model for Design and Evaluation of Efficacy of Different Immunization Strategies for Hepatitis C Virus.
Atcheson E; Li W; Bliss CM; Chinnakannan S; Heim K; Sharpe H; Hutchings C; Dietrich I; Nguyen D; Kapoor A; Jarvis MA; Klenerman P; Barnes E; Simmonds P
Hepatology; 2020 Mar; 71(3):794-807. PubMed ID: 31400152
[TBL] [Abstract][Full Text] [Related]
7. Naturally occurring CD4+ T-cell epitope variants act as altered peptide ligands leading to impaired helper T-cell responses in hepatitis C virus infection.
Cusick MF; Yang M; Gill JC; Eckels DD
Hum Immunol; 2011 May; 72(5):379-85. PubMed ID: 21377503
[TBL] [Abstract][Full Text] [Related]
8. Novel adenovirus-based vaccines induce broad and sustained T cell responses to HCV in man.
Barnes E; Folgori A; Capone S; Swadling L; Aston S; Kurioka A; Meyer J; Huddart R; Smith K; Townsend R; Brown A; Antrobus R; Ammendola V; Naddeo M; O'Hara G; Willberg C; Harrison A; Grazioli F; Esposito ML; Siani L; Traboni C; Oo Y; Adams D; Hill A; Colloca S; Nicosia A; Cortese R; Klenerman P
Sci Transl Med; 2012 Jan; 4(115):115ra1. PubMed ID: 22218690
[TBL] [Abstract][Full Text] [Related]
9. Early interferon therapy for hepatitis C virus infection rescues polyfunctional, long-lived CD8+ memory T cells.
Badr G; Bédard N; Abdel-Hakeem MS; Trautmann L; Willems B; Villeneuve JP; Haddad EK; Sékaly RP; Bruneau J; Shoukry NH
J Virol; 2008 Oct; 82(20):10017-31. PubMed ID: 18667516
[TBL] [Abstract][Full Text] [Related]
10. Lasting differential gene expression of circulating CD8 T cells in chronic HCV infection with cirrhosis identifies a role for Hedgehog signaling in cellular hyperfunction.
Li J; Vranjkovic A; Read D; Delaney SP; Stanford WL; Cooper CL; Crawley AM
Front Immunol; 2024; 15():1375485. PubMed ID: 38887299
[TBL] [Abstract][Full Text] [Related]
11. Adenoviruses vectored hepatitis C virus vaccine cocktails induce broadly specific immune responses against multi-genotypic HCV in mice.
Luo S; Zhang P; Wang Y; Huang Y; Ma X; Deng Q; Zou P; Wang C; Zhang L; Li Y; Fu Y; Li T; Li C
Biomed Pharmacother; 2024 Jan; 170():115901. PubMed ID: 38056238
[TBL] [Abstract][Full Text] [Related]
12. Transient immunological control during acute hepatitis C virus infection: ex vivo analysis of helper T-cell responses.
Ulsenheimer A; Lucas M; Seth NP; Tilman Gerlach J; Gruener NH; Loughry A; Pape GR; Wucherpfennig KW; Diepolder HM; Klenerman P
J Viral Hepat; 2006 Oct; 13(10):708-14. PubMed ID: 16970603
[TBL] [Abstract][Full Text] [Related]
13. Immune Correlates of Natural HIV Elite Control and Simultaneous HCV Clearance-Supercontrollers.
Dominguez-Molina B; Ferrando-Martinez S; Tarancon-Diez L; Hernandez-Quero J; Genebat M; Vidal F; Muñoz-Fernandez MA; Leal M; Koup R; Ruiz-Mateos E
Front Immunol; 2018; 9():2897. PubMed ID: 30619267
[TBL] [Abstract][Full Text] [Related]
14. Phase I Trial of a Therapeutic DNA Vaccine for Preventing Hepatocellular Carcinoma from Chronic Hepatitis C Virus (HCV) Infection.
Jacobson JM; Zahrieh D; Strand CA; Cruz-Correa M; Pungpapong S; Roberts LR; Mandrekar SJ; Rodriguez LM; Boyer J; Marrero I; Kraynyak KA; Morrow MP; Sylvester AJ; Pawlicki JM; Gillespie E; Barranco E; Richmond E; Umar A; Weiner DB; Limburg PJ;
Cancer Prev Res (Phila); 2023 Mar; 16(3):163-173. PubMed ID: 36534786
[TBL] [Abstract][Full Text] [Related]
15. CD4+ primary T cells expressing HCV-core protein upregulate Foxp3 and IL-10, suppressing CD4 and CD8 T cells.
Fernandez-Ponce C; Dominguez-Villar M; Aguado E; Garcia-Cozar F
PLoS One; 2014; 9(1):e85191. PubMed ID: 24465502
[TBL] [Abstract][Full Text] [Related]
16. Ex vivo analysis of human memory CD4 T cells specific for hepatitis C virus using MHC class II tetramers.
Day CL; Seth NP; Lucas M; Appel H; Gauthier L; Lauer GM; Robbins GK; Szczepiorkowski ZM; Casson DR; Chung RT; Bell S; Harcourt G; Walker BD; Klenerman P; Wucherpfennig KW
J Clin Invest; 2003 Sep; 112(6):831-42. PubMed ID: 12975468
[TBL] [Abstract][Full Text] [Related]
17. Induction of intrahepatic HCV NS4B, NS5A and NS5B-specific cellular immune responses following peripheral immunization.
Lang Kuhs KA; Toporovski R; Yan J; Ginsberg AA; Shedlock DJ; Weiner DB
PLoS One; 2012; 7(12):e52165. PubMed ID: 23284919
[TBL] [Abstract][Full Text] [Related]
18. Spontaneous hepatitis C viral clearance and hepatitis C chronic infection are associated with distinct cytokine profiles in Mexican patients.
Fierro NA; González-Aldaco K; Torres-Valadez R; Trujillo-Trujillo ME; Roman S; Trujillo-Ochoa JL; Panduro A
Mem Inst Oswaldo Cruz; 2015 Apr; 110(2):267-71. PubMed ID: 25946254
[TBL] [Abstract][Full Text] [Related]
19. Imprinted immune abnormalities in liver transplant patients cured of hepatitis C with antiviral drugs.
Doyle EH; Aloman C; El-Shamy A; Eng FJ; Kim-Schulze S; Rahman A; Schiano T; Heeger P; Branch AD
Liver Transpl; 2024 Jul; 30(7):728-741. PubMed ID: 38315053
[TBL] [Abstract][Full Text] [Related]
20. Serum neutralization activity declines but memory B cells persist after cure of chronic hepatitis C.
Nishio A; Hasan S; Park H; Park N; Salas JH; Salinas E; Kardava L; Juneau P; Frumento N; Massaccesi G; Moir S; Bailey JR; Grakoui A; Ghany MG; Rehermann B
Nat Commun; 2022 Sep; 13(1):5446. PubMed ID: 36114169
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
